Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 May 2025 | Story Lilitha Dingwayo | Photo Lunga Luthuli
Lunga Luthuli
From left to right: Larshan Naicker, Deputy Director: Teaching and Learning, UFS Library and Information Services; Jeannet Molopyane, Director: UFS Library and Information Services; Prof Vasu Reddy, Deputy Vice-Chancellor: Research and Internationalisation; Keitumetse Eister, University Librarian: Central University of Technology; and Dr Monde Madiba, Deputy Director: Collection Development and Management, UFS Library and Information Services

In a celebration of academic excellence, the University of the Free State (UFS) hosted its first multidisciplinary Library and Information Services Honours and Undergraduate Research Conference (LISHURC) on the Bloemfontein Campus on 23 May 2025. The event offered undergraduate and honours students a unique opportunity to present their research in a professional academic setting.

As a collaborative initiative between faculties and Library and Information Services, the conference served to intellectually stimulate young scholars while promoting scholarly engagement among both students and lecturers. 

Distinguished UFS leaders, including Prof Vasu Reddy, Deputy Vice-Chancellor for Research and Internationalisation, and Prof Matseliso Mokhele-Makgalwa, Vice-Dean Research Engagement and Internationalisation in the Faculty of Education, were in attendance as guest speakers.

Prof Reddy highlighted the university’s commitment to ensuring that student research reaches a global audience through open-access platforms such as KovsieScholar. 

“I encourage you to embrace this opportunity not only as a moment of recognition, but as a stepping stone toward future research, postgraduate studies, and professional impact,” he said.  

Prof Mokhele-Makgalwa commended the university’s inter-faculty collaboration, led by Library and Information Services, in creating a platform that nurtures academic inquiry. Reflecting on the growth of the initiative since its inception in 2019, she acknowledged its success in 2025 as a milestone.  

“We must also consider the broader purpose - preparing our students not only as researchers but as global citizens, leaders, and innovators,” she said, adding that critical thinking, problem-solving, and strong communication skills are essential in today’s academic and professional landscape. 

Among the student presenters was Langelihle Malaza, an honours student in Information Systems from the Faculty of Natural and Agricultural Sciences, who shared his insights into his group’s project: 

“Our group focused on designing a centralised digital platform - a website that would serve as a hub for both educational resources and communication for users involved in the Information Technology Service Learning (ITSL) programme.”  

The team also acknowledged the instrumental support of Dr Rouxan Fouche, lecturer in the Department of Computer Science and Informatics, for his valuable guidance on both content and presentation. 

Attendees praised the event for its inspiring atmosphere and academic depth.  

“I am always interested in learning what other students are researching. When I saw this event, I knew I had to attend - and it exceeded my expectations,” said Jabulile Maseko, a master’s student in Zoology.

This event exemplifies the UFS’s commitment to cultivating research excellence and aligns with the institution's Vision 130 – a roadmap to producing globally relevant graduates who are ready to make a difference. 

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept